Barclays’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.82M | Sell |
528,526
-293,306
| -36% | -$4.34M | ﹤0.01% | 1301 |
|
2025
Q1 | $14.7M | Buy |
821,832
+425,262
| +107% | +$7.62M | ﹤0.01% | 839 |
|
2024
Q4 | $6.91M | Buy |
396,570
+227,802
| +135% | +$3.97M | ﹤0.01% | 1361 |
|
2024
Q3 | $2.36M | Sell |
168,768
-17,544
| -9% | -$245K | ﹤0.01% | 2060 |
|
2024
Q2 | $1.53M | Buy |
186,312
+8,555
| +5% | +$70.4K | ﹤0.01% | 1872 |
|
2024
Q1 | $1.37M | Sell |
177,757
-209,052
| -54% | -$1.61M | ﹤0.01% | 2193 |
|
2023
Q4 | $3.48M | Buy |
386,809
+98,155
| +34% | +$882K | ﹤0.01% | 1759 |
|
2023
Q3 | $2.58M | Buy |
288,654
+36,071
| +14% | +$322K | ﹤0.01% | 1509 |
|
2023
Q2 | $3.88M | Buy |
252,583
+49,797
| +25% | +$765K | ﹤0.01% | 1357 |
|
2023
Q1 | $4.56M | Buy |
202,786
+18,000
| +10% | +$405K | ﹤0.01% | 1135 |
|
2022
Q4 | $3.89M | Buy |
184,786
+47,873
| +35% | +$1.01M | ﹤0.01% | 1252 |
|
2022
Q3 | $3.37M | Buy |
136,913
+111,357
| +436% | +$2.74M | ﹤0.01% | 1320 |
|
2022
Q2 | $619K | Sell |
25,556
-23,345
| -48% | -$565K | ﹤0.01% | 2420 |
|
2022
Q1 | $1.26M | Buy |
+48,901
| New | +$1.26M | ﹤0.01% | 2125 |
|
2020
Q4 | – | Sell |
-24,386
| Closed | -$450K | – | 3705 |
|
2020
Q3 | $450K | Sell |
24,386
-14,606
| -37% | -$270K | ﹤0.01% | 2358 |
|
2020
Q2 | $796K | Buy |
38,992
+2,200
| +6% | +$44.9K | ﹤0.01% | 2058 |
|
2020
Q1 | $537K | Sell |
36,792
-38,305
| -51% | -$559K | ﹤0.01% | 2085 |
|
2019
Q4 | $1.07M | Buy |
75,097
+45,744
| +156% | +$650K | ﹤0.01% | 2261 |
|
2019
Q3 | $341K | Sell |
29,353
-15,598
| -35% | -$181K | ﹤0.01% | 2813 |
|
2019
Q2 | $903K | Buy |
44,951
+25,175
| +127% | +$506K | ﹤0.01% | 2401 |
|
2019
Q1 | $447K | Buy |
19,776
+16,351
| +477% | +$370K | ﹤0.01% | 2682 |
|
2018
Q4 | $77K | Sell |
3,425
-28,195
| -89% | -$634K | ﹤0.01% | 3058 |
|
2018
Q3 | $908K | Buy |
31,620
+23,585
| +294% | +$677K | ﹤0.01% | 2304 |
|
2018
Q2 | $220K | Sell |
8,035
-12,154
| -60% | -$333K | ﹤0.01% | 2697 |
|
2018
Q1 | $450K | Buy |
20,189
+8,152
| +68% | +$182K | ﹤0.01% | 2357 |
|
2017
Q4 | $254K | Sell |
12,037
-15,078
| -56% | -$318K | ﹤0.01% | 2508 |
|
2017
Q3 | $675K | Buy |
27,115
+24,943
| +1,148% | +$621K | ﹤0.01% | 1775 |
|
2017
Q2 | $42K | Sell |
2,172
-7,620
| -78% | -$147K | ﹤0.01% | 3074 |
|
2017
Q1 | $180K | Sell |
9,792
-8,649
| -47% | -$159K | ﹤0.01% | 2569 |
|
2016
Q4 | $349K | Buy |
18,441
+14,509
| +369% | +$275K | ﹤0.01% | 2012 |
|
2016
Q3 | $87K | Buy |
3,932
+3,833
| +3,872% | +$84.8K | ﹤0.01% | 2488 |
|
2016
Q2 | $2K | Buy |
+99
| New | +$2K | ﹤0.01% | 3316 |
|
2016
Q1 | – | Sell |
-310,933
| Closed | -$5.91M | – | 3667 |
|
2015
Q4 | $5.91M | Buy |
310,933
+306,903
| +7,615% | +$5.83M | 0.01% | 620 |
|
2015
Q3 | $81K | Sell |
4,030
-248
| -6% | -$4.99K | ﹤0.01% | 2439 |
|
2015
Q2 | $141K | Buy |
4,278
+3,306
| +340% | +$109K | ﹤0.01% | 2222 |
|
2015
Q1 | $22K | Sell |
972
-296
| -23% | -$6.7K | ﹤0.01% | 3071 |
|
2014
Q4 | $16K | Buy |
1,268
+569
| +81% | +$7.18K | ﹤0.01% | 3517 |
|
2014
Q3 | $6K | Buy |
699
+78
| +13% | +$670 | ﹤0.01% | 3911 |
|
2014
Q2 | $7K | Buy |
621
+102
| +20% | +$1.15K | ﹤0.01% | 3796 |
|
2014
Q1 | $11K | Buy |
+519
| New | +$11K | ﹤0.01% | 3764 |
|